The company expired its plan on September 8, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.18 USD | +0.48% |
|
-1.62% | -30.00% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.00% | 5.38M | |
+15.58% | 122B | |
+16.60% | 113B | |
+17.55% | 26.22B | |
-24.33% | 19.01B | |
-19.14% | 15.71B | |
-17.95% | 15.22B | |
-46.81% | 14.72B | |
+58.78% | 14.58B | |
+4.91% | 13.84B |
- Stock Market
- Equities
- KTTA Stock
- News Pasithea Therapeutics Corp.
- Pasithea Therapeutics Corp.'s Equity Buyback announced on July 20, 2023 has expired with 5,323,451 shares, representing 20.36% for $3.73 million.